Russia approves trial of AstraZeneca COVID-19 vaccine: registry filing

Singapore News News

Russia approves trial of AstraZeneca COVID-19 vaccine: registry filing
Singapore Latest News,Singapore Headlines
  • 📰 ChannelNewsAsia
  • ⏱ Reading Time:
  • 41 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 20%
  • Publisher: 66%

AstraZeneca has received regulatory approval to conduct part of a Phase III trial of its potential COVID-19 vaccine, AZD1222, in Russia, a filing ...

Share this contentMOSCOW: Britain's AstraZeneca has received regulatory approval to conduct part of a Phase III trial of its potential COVID-19 vaccine in Russia, a filing in the Russian registry of clinical trials showed on Friday .

The trial of the AZD1222 vaccine will involve 150 participants and will be handled by four medical facilities in St Petersburg and Moscow, the filing, dated Friday, showed.Moscow has previously agreed a deal with AstraZeneca to manufacture the potential vaccine, developed in tandem with Oxford University, at the facilities of Russian firm R-Pharm.

The British drugmaker said in a statement last week that late-stage trials of its vaccine were ongoing in Britain and in Brazil, an early-stage trial was progressing in South Africa, and that further trials were planned in the U.S., Japan and Russia. Russia is also developing several potential COVID-19 vaccines domestically, with late-stage trials of the front-runner candidate, nicknamed 'Sputnik-V', set to begin next week.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

ChannelNewsAsia /  🏆 6. in SG

Singapore Latest News, Singapore Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Russia to begin COVID-19 vaccine trials on 40,000 people next weekRussia to begin COVID-19 vaccine trials on 40,000 people next weekMass testing of Russia's first potential COVID-19 vaccine to get domestic regulatory approval will involve more than 40,000 people and will be overseen by a foreign research body when it starts next week, backers of the project said on Thursday. The vaccine, called 'Sputnik V' in homage
Read more »

Russia to test COVID-19 vaccine on 40,000 peopleRussia to test COVID-19 vaccine on 40,000 peopleRussia said on Thursday it would start clinical trials of its controversial coronavirus vaccine next week, involving tens of thousands of people.
Read more »

Russia COVID-19 vaccine roll-out plan prompts virus mutation worriesRussia COVID-19 vaccine roll-out plan prompts virus mutation worriesLONDON: Russia's plan to roll-out its 'Sputnik-V' COVID-19 vaccine even before full trials show how well it works is prompting concern among virus ...
Read more »

Don't drink the tea: Poison is a favoured weapon in RussiaDon't drink the tea: Poison is a favoured weapon in RussiaMOSCOW (NYTIMES) - Without the slightest premonition of any issues with his health, Pyotr Verzilov, a Russian opposition activist, suddenly fell violently ill two years ago and slipped into a coma, a common problem for opponents of the Kremlin.. Read more at straitstimes.com.
Read more »

Russia to test coronavirus vaccine on 40,000 peopleRussia to test coronavirus vaccine on 40,000 peopleRussia said on Thursday it would start clinical trials of its controversial coronavirus vaccine next week, involving tens of thousands of people.
Read more »

We demand clarity on how Navalny fell ill, Merkel tells RussiaWe demand clarity on how Navalny fell ill, Merkel tells RussiaBERLIN (REUTERS) - Germany insists that the circumstances that led to Russian opposition politician Alexei Navalny being taken suddenly ill be cleared up, Chancellor Angela Merkel said, adding that the information so far available did not look good.. Read more at straitstimes.com.
Read more »



Render Time: 2025-04-07 21:04:14